A carregar...
MUCIN-4 (MUC4) is a novel tumor antigen for pancreatic cancer immunotherapy
Pancreatic cancer (PC) is a highly lethal malignancy with a dismal five-year survival rate. This is due to its asymptomatic nature, lack of reliable biomarkers, poor resectability, early metastasis, and high recurrence rate. Limited efficacies of current treatment modalities and treatment-associated...
Na minha lista:
| Publicado no: | Semin Immunol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7160012/ https://ncbi.nlm.nih.gov/pubmed/31952903 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.smim.2020.101391 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|